Work

Phase I study of plerixafor and bevacizumab in recurrent high-grade glioma.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.2031

Authors: Katrina H. Smith, Eudocia Quant Lee, Alona Muzikansky, Elizabeth Robins Gerstner, Dan G. Duda, David A. Reardon, Lakshmi Nayak, Andrew David Norden, Lisa M. Doherty, Jennifer Rifenburg, Debra C. LaFrankie, Sandra Ruland, Julee Pulverenti, Deirdre Stokes, Priscilla Lam, Christine Sceppa McCluskey, Sarah C. Gaffey, Tracy Batchelor, Rakesh K. Jain, Patrick Y. Wen

Institutions: Dana-Farber Cancer Institute, Massachusetts General Hospital, Harvard University

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4241746608

Cites:

Cited by: 2

Related to: 10